API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
46
PharmaCompass offers a list of Sodium Polystyrene Sulfonate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Polystyrene Sulfonate manufacturer or Sodium Polystyrene Sulfonate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Polystyrene Sulfonate manufacturer or Sodium Polystyrene Sulfonate supplier.
PharmaCompass also assists you with knowing the Sodium Polystyrene Sulfonate API Price utilized in the formulation of products. Sodium Polystyrene Sulfonate API Price is not always fixed or binding as the Sodium Polystyrene Sulfonate Price is obtained through a variety of data sources. The Sodium Polystyrene Sulfonate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 4-Ethenylbenzenesulfonic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4-Ethenylbenzenesulfonic Acid, including repackagers and relabelers. The FDA regulates 4-Ethenylbenzenesulfonic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4-Ethenylbenzenesulfonic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 4-Ethenylbenzenesulfonic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 4-Ethenylbenzenesulfonic Acid supplier is an individual or a company that provides 4-Ethenylbenzenesulfonic Acid active pharmaceutical ingredient (API) or 4-Ethenylbenzenesulfonic Acid finished formulations upon request. The 4-Ethenylbenzenesulfonic Acid suppliers may include 4-Ethenylbenzenesulfonic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of 4-Ethenylbenzenesulfonic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 4-Ethenylbenzenesulfonic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of 4-Ethenylbenzenesulfonic Acid active pharmaceutical ingredient (API) in detail. Different forms of 4-Ethenylbenzenesulfonic Acid DMFs exist exist since differing nations have different regulations, such as 4-Ethenylbenzenesulfonic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 4-Ethenylbenzenesulfonic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. 4-Ethenylbenzenesulfonic Acid USDMF includes data on 4-Ethenylbenzenesulfonic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 4-Ethenylbenzenesulfonic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 4-Ethenylbenzenesulfonic Acid suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 4-Ethenylbenzenesulfonic Acid Drug Master File in Japan (4-Ethenylbenzenesulfonic Acid JDMF) empowers 4-Ethenylbenzenesulfonic Acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 4-Ethenylbenzenesulfonic Acid JDMF during the approval evaluation for pharmaceutical products. At the time of 4-Ethenylbenzenesulfonic Acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 4-Ethenylbenzenesulfonic Acid suppliers with JDMF on PharmaCompass.
A 4-Ethenylbenzenesulfonic Acid written confirmation (4-Ethenylbenzenesulfonic Acid WC) is an official document issued by a regulatory agency to a 4-Ethenylbenzenesulfonic Acid manufacturer, verifying that the manufacturing facility of a 4-Ethenylbenzenesulfonic Acid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 4-Ethenylbenzenesulfonic Acid APIs or 4-Ethenylbenzenesulfonic Acid finished pharmaceutical products to another nation, regulatory agencies frequently require a 4-Ethenylbenzenesulfonic Acid WC (written confirmation) as part of the regulatory process.
click here to find a list of 4-Ethenylbenzenesulfonic Acid suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 4-Ethenylbenzenesulfonic Acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 4-Ethenylbenzenesulfonic Acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 4-Ethenylbenzenesulfonic Acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 4-Ethenylbenzenesulfonic Acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 4-Ethenylbenzenesulfonic Acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 4-Ethenylbenzenesulfonic Acid suppliers with NDC on PharmaCompass.
4-Ethenylbenzenesulfonic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 4-Ethenylbenzenesulfonic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 4-Ethenylbenzenesulfonic Acid GMP manufacturer or 4-Ethenylbenzenesulfonic Acid GMP API supplier for your needs.
A 4-Ethenylbenzenesulfonic Acid CoA (Certificate of Analysis) is a formal document that attests to 4-Ethenylbenzenesulfonic Acid's compliance with 4-Ethenylbenzenesulfonic Acid specifications and serves as a tool for batch-level quality control.
4-Ethenylbenzenesulfonic Acid CoA mostly includes findings from lab analyses of a specific batch. For each 4-Ethenylbenzenesulfonic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
4-Ethenylbenzenesulfonic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (4-Ethenylbenzenesulfonic Acid EP), 4-Ethenylbenzenesulfonic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (4-Ethenylbenzenesulfonic Acid USP).